首页|丹参注射液调控TGF-β/Smad信号通路抑制腹膜透析液诱导HMrSV5细胞内皮-间充质转化机制

丹参注射液调控TGF-β/Smad信号通路抑制腹膜透析液诱导HMrSV5细胞内皮-间充质转化机制

扫码查看
目的 研究丹参注射液对腹膜透析液诱导HMrSV5细胞发生内皮-间充质转化(EndMT)的影响,并从TGF-β/Smad信号通路分析其可能的作用机制。方法 CCK-8法、Western blotting筛选腹膜透析液诱导HMrSV5细胞发生EndMT的形成条件及丹参注射液安全浓度范围;取HMrSV5细胞,随机分成正常组、模型组、丹参注射液0。05%、0。1%、0。5%浓度组,除正常组外,其余各组加入40%腹膜透析液培养72 h诱发细胞EndMT,实验结束前24 h,各组加入不同浓度丹参注射液。CCK-8法检测细胞活力;ELISA法检测细胞上清中白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、转化生长因子-β(TGF-β)和血管内皮生长因子(VEGF)水平;Western blotting检测各组细胞E-钙粘着蛋白(E-cadherin)、α-平滑肌激动蛋白(α-SMA)、p-Smad 2/3和Smad 7蛋白表达影响。结果 40%的腹膜透析液诱导HMrSV5细胞72 h后,可发生明显的EndMT;丹参注射液安全浓度范围为0。025%~1。5%。与正常组比较,模型组细胞活力下降;IL-6、TNF-α、TGF-β和VEGF水平升高;α-SMA、p-Smad 2/3等蛋白表达上调;E-cadherin和Smad7蛋白表达明显下降,差异有统计学意义(P<0。05)。与模型组比,丹参注射液各浓度组可增加细胞活力,提高E-cadherin和Smad7蛋白表达,降低IL-6、TNF-α、TGF-β、VEGF水平和α-SMA、p-Smad2/3蛋白表达(P<0。05)。结论 丹参注射液对腹膜透析液诱导的EndMT有一定的改善作用,其机制可能与抑制TGF-β/Smad信号通路有关。
Danshen Injection inhibits peritoneal dialysis fluid-induced endothelial-mesenchymal transition in HMrSV5 cells by regulating the TGF-β/Smad signaling pathway
Objective To investigate the inhibitory effect of Danshen Injection on endothelial-mesenchymal transition(EndMT)induced by peritoneal dialysis fluid in HMrSV5 cells and the role of the TGF-β/Smad signaling pathway in mediating this effect.Methods HMrSV5 cells cultured in 40%peritoneal dialysis solution for 72 h to induce EndMT were treated with 0.05%,0.1%and 0.5%Danshen Injection.CCK-8 assay was used to assess the changes in viability of the treated cells,and the levels of interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),transforming growth factor-β(TGF-β),and vascular endothelial growth factor(VEGF)in the cell supernatant were detected using ELISA;Western blotting was performed to detect the protein expressions of E-cadherin,α-smooth muscle actin(α-SMA),p-Smad 2/3,and Smad 7 in the cells.Results Culture in 40%peritoneal dialysis fluid for 72 induced significant EndMT in HMrSV5 cells,which exhibited obviously lowered cell viability.Danshen Injection within the concentration range of 0.025%-1.5%did not significantly affect the viability of the cells.Exposure of HMrSV5 cells to peritoneal dialysis fluid for 72 h significantly increased the production of IL-6,TNF-α,TGF-β and VEGF,upregulated the protein expressions of α-SMA and p-Smad 2/3,and lowered the expressions of E-cadherin and Smad7 proteins.Treatment of the exposed cells with Danshen injection significantly increased cell viability and cellular expressions of E-cadherin and Smad 7 proteins and reduced the production of IL-6,TNF-α,TGF-β and VEGF and the protein expressions of α-SMA and p-Smad 2/3.Conclusion Danshen Injection can suppress peritoneal dialysis fluid-induced EndMT in HMrSV5 cells possibly by regulating the TGF-β/Smad signaling pathway.

Danshen Injectionperitoneal dialysateendothelial-mesenchymal transitionTGF-β/Smad signaling pathwayperitoneal fibrosis

俞丽华、李静雅、王晓琪、李莉、陈娅、王飞宇、张坤、王桐生

展开 >

安徽中医药大学中西结合学院生理与药理学系,安徽 合肥 230012

安徽中医药大学附属太和中医院肾病科,安徽 太和 236600

安徽中医药大学药学院,安徽 合肥 230012

丹参注射液 腹膜透析液 内皮-间充质转化 TGF-β/Smad信号通路 腹膜纤维化

2024

南方医科大学学报
南方医科大学

南方医科大学学报

CSTPCD北大核心
影响因子:1.654
ISSN:1673-4254
年,卷(期):2024.44(12)